We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




E. coli Fingerprint Solves Cookie Dough Mystery

By LabMedica International staff writers
Posted on 25 Jun 2009
A genomic fingerprinting approach was used to identify the strain of the Escherichia coli O157:H7, which has been incriminated in the raw cookie dough scare in the United States. More...
The E. coli O157:H7 is a strain not previously associated with eating raw cookie dough, but can be toxic to the kidney and in the worst cases, fatal.

The U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), the state health departments, federal regulatory partners, and many companies have been working together in the ongoing investigation to identify the E. coli strain responsible for the outbreak.

The CDC used a long polymerase chain reaction (PCR)-amplified ribosomal DNA (rDNA) for PCR restriction fragment length polymorphism (PCR-RFLP)- and Rep-PCR-based approach to recognize the culprit E.coli strain. Long PCR can be used to amplify fragments of bacterial ribosomal operons. Rep-PCR is a genomic fingerprinting method based on the use of DNA primers corresponding to naturally occurring interspersed repetitive elements in bacteria, such as the REP, ERIC, and BOX elements, and the PCR reaction (rep-PCR).

As of June 22, 2009, 70 persons infected with an E. coli O157:H7 with the DNA fingerprint of the strain have been reported from 30 states in the USA.

Related Links:

U.S. Centers for Disease Control and Prevention




Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.